Pfizer Inc (BUE:PFE)
ARS 7671.5 110 (1.45%) Market Cap: 142.34 Til Enterprise Value: 192.49 Til PE Ratio: 0 PB Ratio: 1.75 GF Score: 58/100

Pfizer Inc To Acquire Arena Pharmaceuticals Inc - M&A Call Transcript

Dec 13, 2021 / 03:00PM GMT
Release Date Price: ARS5615 (+1.70%)
Operator

Good day, everyone, and welcome to Pfizer's analyst and investor call to discuss the proposed acquisition of Arena Pharmaceuticals, Inc. Today's call is being recorded.

At this time, I would like to turn the call over to Mr. Chris Stevo, Senior Vice President and Chief Investor Relations Officer. Please go ahead, sir.

Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer

Thank you, Sylvia. Good morning, everyone, and thank you for joining us on short notice. We'll be making forward-looking commentary and statements during the call regarding, amongst other topics, our I&I pipeline, in-line products and product candidates and the proposed acquisition of Arena Pharmaceuticals, Inc. by Pfizer, which are subject to risks and uncertainties.

Additional information regarding forward-looking statements is available under Risk Factors and forward-looking information and factors that may affect future results in our SEC filings on Form 10-K and 10-Q and in the press release we issued this morning. Forward-looking statements on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot